When it comes to the left atrial appendage, first do no harm

  • T. Jared Bunch
    Address reprint requests and correspondence: Dr T. Jared Bunch, Intermountain Heart Rhythm Specialists, Intermountain Medical Center, Eccles Outpatient Care Center, 5169 Cottonwood St, Suite 510, Murray, UT 84107.
    Intermountain Medical Center Heart Institute, Murray, Utah

    Stanford University, Department of Internal Medicine, Palo Alto, California
    Search for articles by this author
Published:August 17, 2019DOI:
      Primum non nocere (“first, do no harm”) is a directive inherent to the practice of medicine. The phrase is often ascribed to the Hippocratic oath; however, it is found in Hippocrates’ treatise Of the Epidemics, which states, “As to diseases, make a habit of two things—to help, or at least, to do no harm.”
      • Markel H.
      "I swear by Apollo"—on taking the Hippocratic oath.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Heart Rhythm
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Markel H.
        "I swear by Apollo"—on taking the Hippocratic oath.
        N Engl J Med. 2004; 350: 2026-2029
        • Kamel H.
        • Okin P.M.
        • Elkind M.S.
        • Iadecola C.
        Atrial fibrillation and mechanisms of stroke: time for a new model.
        Stroke. 2016; 47: 895-900
        • Lodder J.
        • Bamford J.M.
        • Sandercock P.A.
        • Jones L.N.
        • Warlow C.P.
        Are hypertension or cardiac embolism likely causes of lacunar infarction?.
        Stroke. 1990; 21: 375-381
        • Chesebro J.H.
        • Fuster V.
        • Halperin J.L.
        Atrial fibrillation—risk marker for stroke.
        N Engl J Med. 1990; 323: 1556-1558
        • Bunch T.J.
        • May H.T.
        Atrial fibrillation: a risk factor or risk marker?.
        Eur Heart J. 2016; 37: 2890-2892
        • Blackshear J.L.
        • Odell J.A.
        Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation.
        Ann Thorac Surg. 1996; 61: 755-759
        • Wysokinski W.E.
        • Ammash N.
        • Sobande F.
        • Kalsi H.
        • Hodge D.
        • McBane R.D.
        Predicting left atrial thrombi in atrial fibrillation.
        Am Heart J. 2010; 159: 665-671
        • Holmes D.R.
        • Alkhouli M.
        • Reddy V.
        Left atrial appendage occlusion for the unmet clinical needs of stroke prevention in nonvalvular atrial fibrillation.
        Mayo Clin Proc. 2019; 94: 864-874
        • Reddy V.Y.
        • Doshi S.K.
        • Kar S.
        • et al.
        5-Year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials.
        J Am Coll Cardiol. 2017; 70: 2964-2975
        • Sivasambu B.
        • Arbab-Zadeh A.
        • Hays A.
        • Calkins H.
        • Berger R.D.
        Delayed endothelialization of watchman device identified with cardiac CT.
        J Cardiovasc Electrophysiol. 2019; 30: 1319-1324
        • Alkhouli M.
        • Busu T.
        • Shah K.
        • Osman M.
        • Alqahtani F.
        • Raybuck B.
        Incidence and clinical impact of device-related thrombus following percutaneous left atrial appendage occlusion: a meta-analysis.
        JACC Clin Electrophysiol. 2018; 4: 1629-1637
        • Saw J.
        • Tzikas A.
        • Shakir S.
        • et al.
        Incidence and clinical impact of device-associated thrombus and peri-device leak following left atrial appendage closure with the Amplatzer cardiac plug.
        JACC Cardiovasc Interv. 2017; 10: 391-399
        • Viles-Gonzalez J.F.
        • Kar S.
        • Douglas P.
        • et al.
        The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF substudy.
        J Am Coll Cardiol. 2012; 59: 923-929
        • Hanke T.
        Surgical management of the left atrial appendage: a must or a myth?.
        Eur J Cardiothorac Surg. 2018; 53: i33-i38
        • Aryana A.
        • Singh S.K.
        • Singh S.M.
        • et al.
        Association between incomplete surgical ligation of left atrial appendage and stroke and systemic embolization.
        Heart Rhythm. 2015; 12: 1431-1437
        • Gianni C.
        • Di Biase L.
        • Trivedi C.
        • et al.
        Clinical implications of leaks following left atrial appendage ligation with the LARIAT device.
        JACC Cardiovasc Interv. 2016; 9: 1051-1057
        • Mohanty S.
        • Gianni C.
        • Trivedi C.
        • et al.
        Risk of thromboembolic events after percutaneous left atrial appendage ligation in patients with atrial fibrillation: long-term results from a multicenter study.
        Heart Rhythm. 2020; 17: 175-181

      Linked Article